Google: Analysts' New Targets, Estimates

Google estimates, target raised at Morgan Stanley. Shares of GOOG now seen reaching $730.
By TheStreet Staff ,

Click here for Analysts' Upgrades, Downgrades.

Editor's Note: Green and red arrows refer to intraday stock price movement.

NEW YORK (

TheStreet

) --

STOCK COMMENTS / EPS CHANGES

Akamai

(AKAM) - Get Report

estimates, target upped at Jefferies. AKAM estimates were boosted through 2011, Jefferies said. Company likely to boost guidance for online video. Hold rating and new $60 price target.

Bio-Rad

(BIO) - Get Report

estimates, target raised at Jefferies.Shares of BIO now seen reaching $127, according to Jefferies. Estimates also increased, to reflect the company's recent debt re-financing. Buy rating.

Ciena

(CIEN) - Get Report

estimates lowered at Citigroup. CIEN estimates were cut through 2011, Citigroup said. Management is talking down guidance. Buy rating and $24 price target.

CME Group

(CME) - Get Report

estimates increased at JP Morgan through 2011. Company is realizing higher trading volumes. Overweight rating.

Express Scripts

(ESRX)

target boosted at Goldman. Shares of ESRX now seen reaching $58, according to Goldman Sachs. Company should continue to benefit from a robust generic pipeline. Neutral rating.

Eaton

(ETN) - Get Report

estimates, target increased at Citigroup. ETN estimates were raised through 2011, Citigroup said. Company is leveraged to rising global CapEx. Buy rating and new $115 price target.

FMC Corp.

(FMC) - Get Report

numbers boosted at Keybanc. Shares of FMC now seen reaching $96, according to Keybanc. Estimates also upped, as the company has improved earnings visibility. Buy rating.

Google

(GOOG) - Get Report

estimates, target raised at Morgan Stanley. Shares of GOOG now seen reaching $730, according to Morgan Stanley. Estimates also increased, given accelerating mobile growth and the benefits from Google Instant. Overweight rating.

Home Depot

(HD) - Get Report

estimates raised at Credit Suisse. HD 2011 and 2012 EPS estimates increased to $1.93 and $2.25, respectively. Significant margin drivers ahead, Credit Suisse said. Maintain Outperform rating and $41 price target.

Starwood Hotels

(HOT)

price target boosted at BofA/Merrill. HOT price target increased to $70 from $62 on strong macro hotel cycle. HOT is our top lodging pick in 2011, Bank of America/Merrill Lynch said. Maintain Buy rating.

Lululemon

(LULU) - Get Report

estimates, target increased at Jefferies. LULU estimates were raised through 2011, Jefferies said. Company can gain market share in the coming quarters. Underperform rating and new $40 price target.

Metlife

(MET) - Get Report

target lower, estimates higher at Barclays. MET price target lowered to $50 from $52 as investor-day confirms mixed outlook, Barclays said. 2010 and 2011 EPS estimates raised to $4.29 and $5.03, respectively. Maintain Overweight rating.

Medco Health

(MHS)

target increased at Goldman to $77. Company should continue to benefit from favorable demographics and benign competition. Buy rating.

Philip Morris

(PM) - Get Report

numbers upped at Goldman. PM estimates were boosted through 2012. Company is raising its prices. Buy rating and new $70 price target.

Sprint Nextel

(S) - Get Report

target raised at Deutsche to $7, according to Deutsche Bank. Company is moving forward with its network modernization plan. Buy rating.

Suntech Power

(STP)

numbers raised at Oppenheimer to $10. Estimates also increased, to match the company's new guidance. Perform rating.

This article was written by a staff member of TheStreet.

Loading ...